Nature Reviews Cancer is a monthly review journal for all researchers working on cancer. We, the editors, highlight the most exciting topics in cancer research.
2019
#NobelPrize
winner William Kaelin
@kaelin_lab
wrote a Perspective article for the journal in 2017 on Common pitfalls in preclinical cancer target validation that many have said should be 'required reading'. Access it for free here:
Tumour-associated lymphatic growth & remodeling were once viewed as passive means for lymphatic spread. In this
#Review
,
@theLundLab
provide a working framework for the role of the lymphatic system in tumour progression & response to immunotherapy.
🎉🍾Nature Reviews Cancer is 20! To celebrate we have put together an anniversary issue with articles that look towards the future of cancer research. All reviews, perspectives and commentaries in the issue are FREE to access for 1 month starting today.
Check out our NEW article by Stefani Spranger & Thomas F. Gajewski discussing how oncogenic tumour pathways can mediate immune evasion & the possibility of targeting these pathways to overcome
#immunotherapy
resistance
Want to hear more about
@AshaniTW
’s opening plenary talk on how the ageing microenvironment influences
#tumour
progression &
#therapy
response? Have a read of her Review here:
#AACR20
In case you missed it...
#Transposableelements
, or junk DNA, constitute nearly 1/2 the
#humangenome
.
@twang5
and colleagues discuss how tumours exploit transposable elements during their evolution & how they could be targeted by immunotherapies.
As a scientist have you ever wondered why you might want a Twitter account? Well find out why in our NEW Comment article by
@SoragniLab
&
@aiims1742
. With lots of helpful tips to get you started....Free to view here....
#ofscientistsandtweets
@NatResCancer
Most studies looking at therapy resistance have focused on tumour-intrinsic changes, yet it's now clear that host responses to different cancer therapies can contribute to tumour regrowth, spread & resistance. Find out more in our Review from Yuval Shaked
Did you know that some patients show extraordinary responses to
#cancer
treatments? What can we learn from these patients to improve responses in more typical patients? Find out more in this Perspective from 2019 by
@PrDavidBowtell
& colleagues:
#Edpicks
Check out our NEW article by Erik Thompson & colleagues
@QUT
outlining the evidence for epithelial–mesenchymal plasticity in
#metastasis
, focusing on recent challenges & controversies, & highlighting strategies to target the process.
#EMT
@NatResCancer
Check out the "Milestones in Cancer"! The last 20 years of basic, transl. & clinical research. A community effort by editors from across
@NatResCancer
. Coordinated by
@NatureMedicine
&
@NatureGenetics
. Enjoy!
Timeline:
Collection: